Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Critical word forwarding with adaptive prediction
High power insulated gate bipolar transistors
Method for cutting C--Mn steel with a fiber laser
Manipulation of an alternative respiratory pathway in photo-autotrophs
Determining phase-specific parameters of a physiological variable
Antitumoral compounds
Firewall-tolerant voice-over-internet-protocol (VoIP) emulating SSL or HTTP sessions embedding voice data in cookies
  Randomly Featured Patents
Ratchet wrench
Exo-atmospheric missile intercept system employing tandem interceptors to overcome unfavorable sun positions
Container including a slider, a reclosable fastener and a track including a ramp
Method and device for checking coin for forgery
Capacitor-triggered electrostatic discharge protection circuit
Vehicular traveling direction measuring system with automatic center coordinate position correction
Group communications system
Non-ablative projectile heat sensitive nose
Merging of products into a database